about
Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disordersMacrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson's disease.Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cellsCharacteristics of language impairment in Parkinson's disease and its influencing factorsSomatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.Repeated intra-nigrostriatal injection of phorbol myristate acetate induces microglial senescence in adult rats.Female genetic distribution bias in mitochondrial genome observed in Parkinson's Disease patients in northern China.Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.Risk of lung cancer in Parkinson's diseaseInhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.Neuronal differentiation of adipose-derived stem cells and their transplantation for cerebral ischemia.Association between Parkinson's disease and risk of colorectal cancer.Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system.Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.Genetic analysis of indel markers in three loci associated with Parkinson's disease.Comparing abnormalities of amplitude of low-frequency fluctuations in multiple system atrophy and idiopathic Parkinson's disease measured with resting-state fMRI.Proteomic fingerprinting of HIV-1-infected human monocyte-derived macrophages: a preliminary report.Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity.LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.Usefulness of cube copying in evaluating clinical profiles of patients with Parkinson disease.Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease.Very early-onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene.CLOCK 3111T/C Variant Correlates with Motor Fluctuation and Sleep Disorders in Chinese Patients with Parkinson's Disease.Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.CLOCK rs1801260 Polymorphism is Associated with Susceptibility to Parkinson's Disease in a Chinese Population.Screening of polymorphisms located in the FGF20 and TMEM175 genes in North Chinese Parkinson's disease patients.Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population.Cognitive deterioration rates in patients with Parkinson's disease from northeastern ChinaBV2 enhanced the neurotrophic functions of mesenchymal stem cells after being stimulated with injured PC12Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients
P50
Q28066787-6A8EF29E-0035-4D48-AEB6-A0152FE078BFQ30951456-EB7EF06D-7B74-42B9-918D-C8BF670EF436Q33750089-1DDED714-E99B-45B2-9C86-B22AB3C158CEQ33810138-28C8D89A-88E8-4837-88A5-425717B37D35Q34358296-3CF0D40E-B99B-4138-82DB-B3A9709C5575Q35083853-C44A9AEA-4B8E-499F-A240-5BB5360B3BFBQ35628403-0E4253BF-BF24-4852-9C8A-0117F6B79EF4Q36224749-8FF5F20B-9038-409E-A6F8-9EF1F8B45DCCQ36316602-0DC6D2BD-CC08-48EE-A77F-315D49D6B897Q36890515-E72B39D1-8840-4817-B648-534AC5C5770BQ37718366-9B59D807-6B63-40C6-B15F-847F3D6B6225Q37720013-F126CA63-3117-43E1-A21C-6564E30CC5C1Q38333903-F8F77120-E068-4D67-B03E-BA957E37C839Q38787847-C80ED89D-11AD-499C-9476-3FB5277A2CF2Q38977609-D8DCE1B5-1435-4B87-BE6F-0CFDE50BA8E2Q38992520-EE8399B4-5197-492B-84C6-42086F8E436CQ41617845-650FDB11-FBD9-4AEC-AA2C-E7B63AF6DDEFQ42693835-AF645FFB-1FF3-4F1A-A79E-225EC6EDA6C0Q44737877-A3D9C837-CAA1-46BB-8CF9-38F3704BF04DQ45814315-D50A8BFF-C875-45CA-BB3B-DF165C778AA6Q46098287-B82157FD-46F9-48AD-AB3C-FD6D59946B1EQ46175486-7282C88F-C7B3-46D8-9B47-5DF467A9AD14Q48218418-17FA4C6B-4F46-4F4C-B23C-6053C83B7618Q48391831-429B5DC3-970D-4E3A-AF11-99EE01078E14Q51164618-9DE6C15C-241B-4A08-9A54-49B2917B02B4Q51763343-219C04D6-630E-41D9-8065-560F3B160912Q52923843-D15642D7-B993-4FF3-9715-3C5890846CD4Q53123828-58FADB4F-6BCE-4D61-8229-C5E081A9211FQ54236052-FE529D4B-41A0-4677-ABA6-84999C5F0D29Q54310586-A538B1D7-8716-48A0-805C-309779C03418Q57154675-A5ADCB6D-B4A5-4F84-980E-FBF2AE4DFB1EQ82939739-76D114B8-3EE8-4981-A3B0-B2E412108B05Q90149825-58A94552-5B6D-41E5-8C96-B67603DED81C
P50
description
researcher
@en
հետազոտող
@hy
name
Xiaoguang Luo
@ast
Xiaoguang Luo
@en
Xiaoguang Luo
@es
Xiaoguang Luo
@nl
type
label
Xiaoguang Luo
@ast
Xiaoguang Luo
@en
Xiaoguang Luo
@es
Xiaoguang Luo
@nl
prefLabel
Xiaoguang Luo
@ast
Xiaoguang Luo
@en
Xiaoguang Luo
@es
Xiaoguang Luo
@nl
P106
P1153
14068714100
P31
P496
0000-0001-9828-0626